Rein Therapeutics (RNTX) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Rein Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $610K and 0 sold $0 of RNTX stock on the open market.
Get emailed when insiders cluster-buy stocks like RNTX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RNTX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $75K | 5 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $551K | 5 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Rein Therapeutics, Inc. insiders reported open-market purchases totaling $610K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Voss Value-Oriented Special Situations Fund, Lp (10% Owner) has the highest Insider Score at 66.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 28SEC | Rickenbach Josef H VonDirector | Buy | 23,19058,014 held (+67%) | $1.06 | $25K | -25.1% | — |
| May 28SEC | Rickenbach Josef H VonDirector | Buy | 15,95034,824 held (+85%) | $1.05 | $17K | -24.4% | — |
| May 28SEC | Rickenbach Josef H VonDirector | Buy | 4,50062,514 held (+8%) | $1.07 | $5K | -25.8% | — |
| May 28SEC | Rickenbach Josef H VonDirector | Buy | 3,42018,874 held (+22%) | $1.04 | $4K | -23.7% | — |
| May 13SEC | James Brian WindsorSee Remarks | Buy | 25,00027,046 held (+1222%) | $1.00 | $25K | -20.6% | — |
| Nov 18SEC | Voss Value Master Fund, Lp10% Owner | Buy | 104,183926,441 held (+13%) | $1.22 | $127K | -34.9% | 25 |
| Oct 28SEC | Voss Value-Oriented Special Situations Fund, Lp10% Owner | Buy | 178,392500,000 held (+55%) | $1.39 | $248K | -42.9% | 66 |
| Oct 28SEC | Voss Value-Oriented Special Situations Fund, Lp10% Owner | Buy | 92,642822,258 held (+13%) | $1.37 | $127K | -42.0% | 66 |
| Oct 28SEC | Voss Value-Oriented Special Situations Fund, Lp10% Owner | Buy | 30,176729,616 held (+4%) | $1.39 | $42K | -42.9% | 66 |
| Oct 28SEC | Voss Value-Oriented Special Situations Fund, Lp10% Owner | Buy | 4,840321,608 held (+2%) | $1.37 | $7K | -42.0% | 66 |
Insiders at Rein Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Voss Value-Oriented Special Situations Fund, Lp10% Owner | $423K | — | Oct 28, 2025 | 66 |
| Voss Value Master Fund, Lp10% Owner | $127K | — | Nov 18, 2025 | 25 |
| Rickenbach Josef H VonDirector | $50K | — | May 28, 2026 | — |
| James Brian WindsorSee Remarks | $25K | — | May 13, 2026 | — |
RNTX stock: common questions
Are Rein Therapeutics, Inc. insiders buying RNTX stock?
In the past 12 months, 4 insiders reported open-market purchases of RNTX worth $610K. The latest was Director Rickenbach Josef H Von bought $25K of RNTX at $1.06 — largest purchase by this insider in our records; raises the stake by 67%.
Are Rein Therapeutics, Inc. insiders selling RNTX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RNTX's 52-week range?
Over the past year RNTX has traded between $0.70 and $1.88. It last closed at $0.79 on Oct 9, 2026.